In Novartis’ favour is that there are plenty of other companies working on IgAN therapies, including Ionis/Roche’s antisense-based complement factor B therapy IONIS-FB-LRx, Omeros’ anti-MASP ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Neuronal deficiency of LGR4 improves ...
Protein bands representing HA-Dyn-K44A were visualized on an Amersham Typhoon instrument (Cytiva) while bands corresponding to β-tubulin was visualized in ChemiDoc XRS+ (Bio-Rad) using SuperSignal TM ...
'Til death do they part. There's more to work than life.
This template should help get you started developing with Vue 3 in Vite.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback